Benjamin Burgin

Benjamin Burgin is a seasoned professional in regulatory affairs with extensive experience spanning over two decades. Currently serving as Vice President of Regulatory Affairs at Heron Therapeutics, Inc. since February 2024, Benjamin previously held senior roles at Veloxis Pharmaceuticals, Inc., including Senior Director and Director of Regulatory Affairs. Prior positions include Director of Regulatory Affairs at KemPharm, Inc., and a consultant at BMB Regulatory Consulting, LLC. Benjamin has a robust background in regulatory operations, having worked at Salix Pharmaceuticals and Schwarz Biosciences in various management and specialist roles. Benjamin began a career at Quintiles and GlaxoWellcome, focusing on regulatory and clinical research. Educationally, Benjamin holds a Bachelor of Science degree in Business Management from North Carolina State University.